New key persons joining Medicortex Finland

The Extraordinary General meeting of Medicortex held on 14^th January 2022 elected Mrs. Anna Tenstam (MSc, MBA) as a new member in the company’s board of directors. Mrs. Tenstam is based in Stockholm, Sweden, and has over 30 years of leadership experience in pharmaceutical, medical devices and medical aesthetics companies worldwide. She has been involved in several successful exits and currently she is acting as a board member and advisor is several medical companies. Mrs. Tenstam has M.Sc. from the University of Uppsala and MBA from the IMD Business School in Lausanne. The other Board members of Medicortex continuing on their duties are Adrian Harel, Mårten Kvist and Tom Palenius.

In addition, Medicortex has appointed Mr. Mikko Laurila (M.Sc.Econ) as the Chief Financial Officer (CFO) of the company beginning on 1 February 2022. Mr. Laurila has served in several financial management positions, including Finance Director and Head of Treasury, at a public company Raisio Plc. Mr. Laurila is joining Medicortex from Railo Partners Oy, a private investment and advisory company. At Medicortex, Mikko Laurila will be responsible for financial management, controlling, as well as for potential mergers & acquisitions in the future. Mikko Laurila has M.Sc. in Accounting and Finance from Turku School of Economics and University of Turku, Finland.

“We are going through an exciting phase at Medicortex - I’m happy to have Mrs. Tenstam on the board of directors and Mr. Laurila in the team.” says Dr. Adrian Harel, CEO of Medicortex. “These resources strengthen our corporate governance and financial management competencies which are the expertise we will need for the planned initial public offering (IPO) and listing later this year as well as for guiding the international growth of the company.” Dr. Harel adds.